Selected research
Industry Research
Constipation Treatment Industry Research Report 2026
Market perspective
The global Constipation Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Constipation Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Constipation Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Constipation Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Constipation Treatment include Abbott, Takeda, Sanofi, Bayer, AstraZeneca, Sucampo Pharmaceuticals, Shionogi, SGYP and Renexxion, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Constipation Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Constipation Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Constipation Treatment Market by Company
Abbott
Takeda
Sanofi
Bayer
AstraZeneca
Sucampo Pharmaceuticals
Shionogi
SGYP
Renexxion
Prestige Brands
Janssen Pharmaceutical
Ironwood Pharmaceuticals
Daewoong
Cosmo Pharmaceuticals
Albireo Pharma
Constipation Treatment Segment by Type
Opioid Induced Constipation
Irritable Bowel Syndrome with Constipation
Chronic Idiopathic Constipation
Constipation Treatment Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Constipation Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Constipation Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Constipation Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Constipation Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Constipation Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Opioid Induced Constipation
- Irritable Bowel Syndrome with Constipation
- Chronic Idiopathic Constipation
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Abbott
- Takeda
- Sanofi
- Bayer
- AstraZeneca
- Sucampo Pharmaceuticals
- Shionogi
- SGYP
- Renexxion
- Prestige Brands
- Janssen Pharmaceutical
- Ironwood Pharmaceuticals
- Daewoong
- Cosmo Pharmaceuticals
- Albireo Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Constipation Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Opioid Induced Constipation
- 2.2.3 Irritable Bowel Syndrome with Constipation
- 2.2.4 Chronic Idiopathic Constipation
- 2.3 Constipation Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Pharmacies
- 2.3.3 Online Pharmacies
- 2.3.4 Retail Pharmacies
- 2.4 Assumptions and Limitations
3 Constipation Treatment Breakdown Data by Type
- 3.1 Global Constipation Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Constipation Treatment Forecasted Market Size by Type (2027-2032)
4 Constipation Treatment Breakdown Data by Application
- 4.1 Global Constipation Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Constipation Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Constipation Treatment Market Perspective (2021-2032)
- 5.2 Global Constipation Treatment Growth Trends by Region
- 5.2.1 Global Constipation Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Constipation Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Constipation Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Constipation Treatment Market Dynamics
- 5.3.1 Constipation Treatment Industry Trends
- 5.3.2 Constipation Treatment Market Drivers
- 5.3.3 Constipation Treatment Market Challenges
- 5.3.4 Constipation Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Constipation Treatment Players by Revenue
- 6.1.1 Global Top Constipation Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Constipation Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Constipation Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Constipation Treatment Head Office and Area Served
- 6.4 Global Constipation Treatment Players, Product Type & Application
- 6.5 Global Constipation Treatment Manufacturers Established Date
- 6.6 Global Constipation Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Constipation Treatment Market Size (2021-2032)
- 7.2 North America Constipation Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Constipation Treatment Market Size by Country (2021-2026)
- 7.4 North America Constipation Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Constipation Treatment Market Size (2021-2032)
- 8.2 Europe Constipation Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Constipation Treatment Market Size by Country (2021-2026)
- 8.4 Europe Constipation Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Constipation Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Constipation Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Constipation Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Constipation Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Constipation Treatment Market Size (2021-2032)
- 10.2 South America Constipation Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Constipation Treatment Market Size by Country (2021-2026)
- 10.4 South America Constipation Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Constipation Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Constipation Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Constipation Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Constipation Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abbott
- 12.1.1 Abbott Company Information
- 12.1.2 Abbott Business Overview
- 12.1.3 Abbott Revenue in Constipation Treatment Business (2021-2026)
- 12.1.4 Abbott Constipation Treatment Product Portfolio
- 12.1.5 Abbott Recent Developments
- 12.2 Takeda
- 12.2.1 Takeda Company Information
- 12.2.2 Takeda Business Overview
- 12.2.3 Takeda Revenue in Constipation Treatment Business (2021-2026)
- 12.2.4 Takeda Constipation Treatment Product Portfolio
- 12.2.5 Takeda Recent Developments
- 12.3 Sanofi
- 12.3.1 Sanofi Company Information
- 12.3.2 Sanofi Business Overview
- 12.3.3 Sanofi Revenue in Constipation Treatment Business (2021-2026)
- 12.3.4 Sanofi Constipation Treatment Product Portfolio
- 12.3.5 Sanofi Recent Developments
- 12.4 Bayer
- 12.4.1 Bayer Company Information
- 12.4.2 Bayer Business Overview
- 12.4.3 Bayer Revenue in Constipation Treatment Business (2021-2026)
- 12.4.4 Bayer Constipation Treatment Product Portfolio
- 12.4.5 Bayer Recent Developments
- 12.5 AstraZeneca
- 12.5.1 AstraZeneca Company Information
- 12.5.2 AstraZeneca Business Overview
- 12.5.3 AstraZeneca Revenue in Constipation Treatment Business (2021-2026)
- 12.5.4 AstraZeneca Constipation Treatment Product Portfolio
- 12.5.5 AstraZeneca Recent Developments
- 12.6 Sucampo Pharmaceuticals
- 12.6.1 Sucampo Pharmaceuticals Company Information
- 12.6.2 Sucampo Pharmaceuticals Business Overview
- 12.6.3 Sucampo Pharmaceuticals Revenue in Constipation Treatment Business (2021-2026)
- 12.6.4 Sucampo Pharmaceuticals Constipation Treatment Product Portfolio
- 12.6.5 Sucampo Pharmaceuticals Recent Developments
- 12.7 Shionogi
- 12.7.1 Shionogi Company Information
- 12.7.2 Shionogi Business Overview
- 12.7.3 Shionogi Revenue in Constipation Treatment Business (2021-2026)
- 12.7.4 Shionogi Constipation Treatment Product Portfolio
- 12.7.5 Shionogi Recent Developments
- 12.8 SGYP
- 12.8.1 SGYP Company Information
- 12.8.2 SGYP Business Overview
- 12.8.3 SGYP Revenue in Constipation Treatment Business (2021-2026)
- 12.8.4 SGYP Constipation Treatment Product Portfolio
- 12.8.5 SGYP Recent Developments
- 12.9 Renexxion
- 12.9.1 Renexxion Company Information
- 12.9.2 Renexxion Business Overview
- 12.9.3 Renexxion Revenue in Constipation Treatment Business (2021-2026)
- 12.9.4 Renexxion Constipation Treatment Product Portfolio
- 12.9.5 Renexxion Recent Developments
- 12.10 Prestige Brands
- 12.10.1 Prestige Brands Company Information
- 12.10.2 Prestige Brands Business Overview
- 12.10.3 Prestige Brands Revenue in Constipation Treatment Business (2021-2026)
- 12.10.4 Prestige Brands Constipation Treatment Product Portfolio
- 12.10.5 Prestige Brands Recent Developments
- 12.11 Janssen Pharmaceutical
- 12.11.1 Janssen Pharmaceutical Company Information
- 12.11.2 Janssen Pharmaceutical Business Overview
- 12.11.3 Janssen Pharmaceutical Revenue in Constipation Treatment Business (2021-2026)
- 12.11.4 Janssen Pharmaceutical Constipation Treatment Product Portfolio
- 12.11.5 Janssen Pharmaceutical Recent Developments
- 12.12 Ironwood Pharmaceuticals
- 12.12.1 Ironwood Pharmaceuticals Company Information
- 12.12.2 Ironwood Pharmaceuticals Business Overview
- 12.12.3 Ironwood Pharmaceuticals Revenue in Constipation Treatment Business (2021-2026)
- 12.12.4 Ironwood Pharmaceuticals Constipation Treatment Product Portfolio
- 12.12.5 Ironwood Pharmaceuticals Recent Developments
- 12.13 Daewoong
- 12.13.1 Daewoong Company Information
- 12.13.2 Daewoong Business Overview
- 12.13.3 Daewoong Revenue in Constipation Treatment Business (2021-2026)
- 12.13.4 Daewoong Constipation Treatment Product Portfolio
- 12.13.5 Daewoong Recent Developments
- 12.14 Cosmo Pharmaceuticals
- 12.14.1 Cosmo Pharmaceuticals Company Information
- 12.14.2 Cosmo Pharmaceuticals Business Overview
- 12.14.3 Cosmo Pharmaceuticals Revenue in Constipation Treatment Business (2021-2026)
- 12.14.4 Cosmo Pharmaceuticals Constipation Treatment Product Portfolio
- 12.14.5 Cosmo Pharmaceuticals Recent Developments
- 12.15 Albireo Pharma
- 12.15.1 Albireo Pharma Company Information
- 12.15.2 Albireo Pharma Business Overview
- 12.15.3 Albireo Pharma Revenue in Constipation Treatment Business (2021-2026)
- 12.15.4 Albireo Pharma Constipation Treatment Product Portfolio
- 12.15.5 Albireo Pharma Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst